Author: OurCrowd

[OurCrowd in Business Wire] Thailand’s RISE and Israel’s OurCrowd launch ROCX Exponential Fund

Nov 14, 2023 | ,

ERUSALEM & BANGKOK–(BUSINESS WIRE)–OurCrowd, a leading global digital investment platform, and RISE, the corporate innovation powerhouse based out of Southeast Asia, today announced the launch of the ROCX (Rise OurCrowd Exponential) Fund. The $50 million fund is Thailand’s first Israel-focused VC fund and will invest in early-stage deep technologies in cybersecurity, AI, HealthTech, semiconductors, quantum computing, ClimateTech, AgTech, FoodTech, and more. Read more here....

Read More

[Oshi in Vegconomist] Debut of World’s first alternative Seafood association signals a new era for fish-free fish & health of our oceans

Nov 13, 2023 |

Future Ocean Foods debuts today as the world’s first alternative seafood association, dedicated to propelling the alt seafood industry into a new era. With an impressive list of inaugural memberships, the alliance already has 36 companies on board, spanning 14 countries. 40% of its members are women founders, and this percentage is set to increase. Read more...

Read More

[Eko Health in PR Newswire] Breakthrough clinical data: Eko Health’s AI significantly improves heart disease detection in primary care

Nov 13, 2023 |

EMERYVILLE, Calif., Nov. 13, 2023 /PRNewswire/ — Eko Health, Inc. (Eko), a leader in AI technology for heart and lung disease detection, today unveiled new clinical data at the 2023 American Heart Association Scientific Sessions. This data demonstrated the real-world clinical efficacy of Eko’s AI-enabled SENSORA™ Platform to quickly and accurately detect structural murmurs associated with valvular heart disease. Valvular heart disease (VHD) is a medical condition present in over 50% of adults over the age of 65. VHD can lead to heart failure, stroke, and death, and if left undetected and untreated, can progress from moderate to severe within one year. Unfortunately, symptoms of VHD are frequently nonspecific, and more than half of patients with moderate to severe disease are asymptomatic, making VHD challenging to detect with conventional medical practice. Read...

Read More

[DarioHealth in PR Newswire] Dario publishes new research demonstrating that Dario users that increased physical activity can maintain reduced blood glucose

Nov 13, 2023 |

NEW YORK, Nov. 13, 2023 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the “Company”), a leader in the global digital health market, announced new research presented at the Diabetes Technology Society 2023 Meeting on November 7, 2023. The new research demonstrated the value of associating physical activity tracking alongside blood sugar tracking for people living with diabetes and pre-diabetes. Read more...

Read More

[Classiq in Classiq] Classiq announces Quantum center for life sciences in collaboration with Nvidia

Nov 13, 2023 |

TEL AVIV, November 13, 2023 – Quantum software pioneer Classiq today unveiled a new industry initiative, the Quantum Computing for Life Sciences & Healthcare Center, formed in collaboration with NVIDIA and the Tel Aviv Sourasky Medical Center. The initiative will champion the development and implementation of quantum algorithms and applications, targeting their transformative potential on life sciences and healthcare. Read more...

Read More